# Robert S. Schwartz, MD, a transformative figure in immunosuppression that revolutionized transplantation

## TL;DR

Dr. Robert Schwartz's work on immunosuppression drugs transformed organ transplantation success.

## Contribution

Pioneered the use of 6-mercaptopurine, establishing immunosuppression as a key transplant field.

## Key findings

- 6-mercaptopurine studies in 1959 advanced clinical organ transplantation.
- Schwartz's work became a cornerstone of transplant success through immunosuppression drugs.

## Abstract

While the transplant community celebrated more than a million transplant patients in the United States, we are reminded that our journey to such a celebratory success is the results of remarkable breakthroughs and brilliant innovators. Among those, immunosuppression drugs are undoubtedly a cornerstone of transplant success, an area where Dr. Robert Schwartz is undeniably a transformative figure and a pioneer. His seminal studies on 6-mercaptopurine in 1959 gave birth to an entirely new specialty of immunosuppression that dramatically accelerated the advancement of clinical organ transplantation.